Histamine release from a gastric carcinoid: provocation by pentagastrin and inhibition by somatostatin.

Roberts LJ, Bloomgarden ZT, Marney SR, Rabin D, Oates JA
Gastroenterology. 1983 84 (2): 272-5

PMID: 6184258

We have previously reported that flushing associated with a gastric carcinoid tumor can be provoked by pentagastrin and inhibited by either somatostatin or combined histamine H1- and H2-receptor blockade. In this report, the effects of pentagastrin and somatostatin on histamine release in a patient with a metastatic gastric carcinoid tumor were examined. Small doses of intravenous pentagastrin (0.1-0.4 micrograms) produced a dose-dependent increase in the level of circulating plasma histamine. Graded infusions of somatostatin suppressed both basal and pentagastrin-stimulated plasma histamine levels in a dose-dependent fashion. A close correlation was found between circulating plasma histamine levels and attendant changes in blood pressure and pulse rate. This study documents that pentagastrin directly evokes the release of histamine from this patient's gastric carcinoid tumor and that the release of histamine is inhibited by somatostatin. In addition, this study provides additional evidence that the primary mediator of the flushing in this patient with foregut carcinoid syndrome is histamine.

MeSH Terms (14)

Blood Pressure Carcinoid Tumor Depression, Chemical Dose-Response Relationship, Drug Female Histamine Histamine Release Humans Middle Aged Pentagastrin Pulse Somatostatin Stimulation, Chemical Stomach Neoplasms

Connections (1)

This publication is referenced by other Labnodes entities: